Devajit Mohajan, Haradhan Kumar Mohajan. Alpha-Glucosidase Inhibitors (AGIs): A New Class of Oral Medication for Treatment of Type 2 Diabetes Patients. JIMR [nternet]. 2024 Nov. 12 [cited 2025 Apr. 30];3(4):1-6. vailable from: https://www.paradigmpress.org/jimr/article/view/1381